0000950170-24-084295.txt : 20240717
0000950170-24-084295.hdr.sgml : 20240717
20240717163005
ACCESSION NUMBER: 0000950170-24-084295
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240715
FILED AS OF DATE: 20240717
DATE AS OF CHANGE: 20240717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reich Samuel J
CENTRAL INDEX KEY: 0001394645
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39871
FILM NUMBER: 241122565
MAIL ADDRESS:
STREET 1: ACUITY PHARMACEUTICALS INC
STREET 2: 3701 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001833214
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 853899721
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 W 41ST ST
STREET 2: SUITE 401
CITY: MIAMI BEACH
STATE: FL
ZIP: 33140
BUSINESS PHONE: 305-845-2813
MAIL ADDRESS:
STREET 1: 777 W 41ST ST
STREET 2: SUITE 401
CITY: MIAMI BEACH
STATE: FL
ZIP: 33140
FORMER COMPANY:
FORMER CONFORMED NAME: Big Cypress Acquisition Corp.
DATE OF NAME CHANGE: 20201120
4
1
ownership.xml
4
X0508
4
2024-07-15
0001833214
SAB Biotherapeutics, Inc.
SABS
0001394645
Reich Samuel J
777 W 41ST ST
SUITE 401
MIAMI BEACH
FL
33140
true
true
false
false
CEO & EXECUTIVE CHAIRMAN
false
Stock Option (right to buy)
2.9
2024-07-15
4
A
false
35700
0
A
2034-07-15
Common Stock
35700
35700
D
Represents a one-time grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest 25% on July 15, 2025, and in equal monthly installments thereafter over a three-year period ending July 15, 2028.
This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.
/s/ Samuel J. Reich
2024-07-17